Literature DB >> 36112205

Influence of NaCl and pH on lysostaphin catalytic activity, cell binding, and bacteriolytic activity.

Svetlana Konstantinova1, Alexander Grishin2,3, Alexander Lyashchuk1, Irina Vasina1, Anna Karyagina1,4,5, Vladimir Lunin1,4.   

Abstract

Peptidoglycan-degrading enzymes are a group of proteins intensively studied as novel antibacterials, with some of them having reached pre-clinical and clinical stages of research. Many peptidoglycan-degrading enzymes have modular organization and consist of a catalytic and a cell wall binding domain. This property has been exploited in enzyme engineering efforts, and many new peptidoglycan-degrading enzymes were generated through domain exchange. However, rational combination of domains from different enzymes is still challenging since relative contribution of every domain to the cumulative bacteriolytic activity is not yet clearly understood. In this work, we investigated the influence of ionic strength and pH on the catalytic efficiency and cell binding of peptidoglycan-degrading enzyme lysostaphin and how this influence is reflected in the lysostaphin bacteriolytic activity. Contrary to generally accepted view, lysostaphin domains are not completely independent and their combination within one protein leads to increased bacteriolytic activity with increasing NaCl concentration, despite both catalysis and cell binding being inhibited by NaCl. This effect is likely mediated by changes in conformation of bacterial cell wall peptidoglycan rather than the physical inter-domain interaction. KEY POINTS: • NaCl enhances bacteriolytic activity of lysostaphin but not of its catalytic domain. • Catalytic activity and cell binding of lysostaphin are inhibited by NaCl. • Peptidoglycan conformation likely affects lysostaphin bacteriolytic activity.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Cell wall; Ionic strength; Molecular conformation; Peptide hydrolases; Peptidoglycan; Staphylococcus

Mesh:

Substances:

Year:  2022        PMID: 36112205     DOI: 10.1007/s00253-022-12173-w

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   5.560


  51 in total

1.  LYSOSTAPHIN: ENZYMATIC MODE OF ACTION.

Authors:  H P BROWDER; W A ZYGMUNT; J R YOUNG; P A TAVORMINA
Journal:  Biochem Biophys Res Commun       Date:  1965-04-23       Impact factor: 3.575

2.  A standardized approach for accurate quantification of murein hydrolase activity in high-throughput assays.

Authors:  Yves Briers; Rob Lavigne; Guido Volckaert; Kirsten Hertveldt
Journal:  J Biochem Biophys Methods       Date:  2006-11-10

3.  Differentially conserved staphylococcal SH3b_5 cell wall binding domains confer increased staphylolytic and streptolytic activity to a streptococcal prophage endolysin domain.

Authors:  Stephen C Becker; Juli Foster-Frey; Angeline J Stodola; Daniel Anacker; David M Donovan
Journal:  Gene       Date:  2009-05-05       Impact factor: 3.688

4.  Design of a polypeptide FRET substrate that facilitates study of the antimicrobial protease lysostaphin.

Authors:  Philip Bardelang; Mireille Vankemmelbeke; Ying Zhang; Hannah Jarvis; Eleni Antoniadou; Sophie Rochette; Neil R Thomas; Christopher N Penfold; Richard James
Journal:  Biochem J       Date:  2009-03-15       Impact factor: 3.857

Review 5.  LysM, a widely distributed protein motif for binding to (peptido)glycans.

Authors:  Girbe Buist; Anton Steen; Jan Kok; Oscar P Kuipers
Journal:  Mol Microbiol       Date:  2008-05       Impact factor: 3.501

Review 6.  Catalytic diversity and cell wall binding repeats in the phage-encoded endolysins.

Authors:  Sebastian S Broendum; Ashley M Buckle; Sheena McGowan
Journal:  Mol Microbiol       Date:  2018-11-13       Impact factor: 3.501

7.  Influence of Bacterial Culture Medium on Peptidoglycan Binding of Cell Wall Lytic Enzymes.

Authors:  Amala Bhagwat; Fuming Zhang; Cynthia H Collins; Jonathan S Dordick
Journal:  J Biotechnol       Date:  2021-02-27       Impact factor: 3.307

8.  The phage K lytic enzyme LysK and lysostaphin act synergistically to kill MRSA.

Authors:  Stephen C Becker; Juli Foster-Frey; David M Donovan
Journal:  FEMS Microbiol Lett       Date:  2008-08-21       Impact factor: 2.742

9.  Architecture and assembly of the Gram-positive cell wall.

Authors:  Morgan Beeby; James C Gumbart; Benoît Roux; Grant J Jensen
Journal:  Mol Microbiol       Date:  2013-04-22       Impact factor: 3.501

10.  Engineering of the CHAPk Staphylococcal Phage Endolysin to Enhance Antibacterial Activity against Stationary-Phase Cells.

Authors:  Sara Arroyo-Moreno; Máire Begley; Kornelia Dembicka; Aidan Coffey
Journal:  Antibiotics (Basel)       Date:  2021-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.